• Sujit Kumar Tripathy, Rao P Bhaskar PB Dept. of Anesthesia and Critical Care, All India Institute of Medical Sciences, Bhubaneswar, India., Saurav Narayan Nanda, Chandrakanta Nayak, Barada P Samal, Mantu Jain, Anand Srinivasan, and Debasish Hota.
• Dept. of Orthopedics, All India Institute of Medical Sciences, Bhubaneswar 751019, India. Electronic address: sujitortho@aiimsbhubaneswar.edu.in.
• Knee. 2020 Jan 1; 27 (1): 229-234.

BackgroundAntifibrinolytic drugs are widely used to minimize blood loss and transfusion requirements in total knee arthroplasty (TKA). Although tranexamic acid (TXA) has been widely studied for its use in TKA, there are limited studies on epsilon-aminocaproic acid (EACA).MethodsIn a double-blind randomized control trial, all patients (n = 91) operated with bilateral simultaneous TKA were randomly given either intravenous EACA or placebo (normal saline). A single surgeon performed the TKA with posterior-stabilized implants under tourniquet. A suction drain was placed and kept for 48 h postoperatively. The intraoperative blood loss and drain output were calculated. The postoperative hemoglobin (Hb), drop in Hb, total blood loss, and number of blood transfusions in each group were calculated.ResultsBoth of the groups were comparable in terms of age, sex, body mass index, and pre-operative Hb. There was a significant difference between the EACA group and control group in terms of intraoperative blood loss (150 ml vs. 165 ml, P = 0.01), drain output (494 ml vs. 1062 ml, P < 0.001), postoperative Hb (9.9 g/dl vs. 8.6 g/dl, P = 0.002), drop in Hb (2.2 g/dl vs. 3.1 g/dl, P = 0.026) and transfusion rate (median transfusion 0 vs. 1, P < 0.001). The total blood loss, as calculated by the Hb balance method, was significantly less (P < 0.001) in the EACA group (0.99 l) compared with the control group (2.71 l). None of the patients developed any adverse reaction/complication to the drug.ConclusionIntraoperative administration of EACA significantly decreased the blood loss and postoperative transfusion rates compared with no antifibrinolytic therapy in bilateral simultaneous TKA.Copyright © 2019 Elsevier B.V. All rights reserved.

30 keywords...

hide…